首页 | 本学科首页   官方微博 | 高级检索  
     

甘精胰岛素联合阿卡波糖与门冬胰岛素30治疗高龄初诊2型糖尿病的临床疗效比较
引用本文:全会标,高勇义,陈道雄,陈开宁,方团育. 甘精胰岛素联合阿卡波糖与门冬胰岛素30治疗高龄初诊2型糖尿病的临床疗效比较[J]. 现代预防医学, 2011, 38(18): 3816-3817
作者姓名:全会标  高勇义  陈道雄  陈开宁  方团育
作者单位:海南省人民医院内分泌科,海口,570311
摘    要:[目的]比较甘精胰岛素联合阿卡波糖与门冬胰岛素30治疗高龄2型糖尿病的疗效和安全性。[方法]将72例初诊高龄2型糖尿病患者随机分为甘精胰岛素联合阿卡波糖组(A组)和门冬胰岛素30每日2次组(B组),观察两组血糖达标的时间、胰岛素日平均用量、低血糖发生率。[结果]两组在血糖达标时间上差异无统计学意义,A组胰岛素日平均用量、低血糖发生率均显著低于B组(P﹤0.01)。[结论]甘精胰岛素联合阿卡波糖治疗高龄2型糖尿病安全、有效、方法简单易行。

关 键 词:2型糖尿病  高龄  甘精胰岛素  阿卡波糖  门冬胰岛素30

CLINICAL COMPARISON OF GLARGINE COMBINED WITH ACARBOSE AND INSULIN ASPART 30 IN TREATMENT OF THE NEWLY DIAGNOSED ELDER TYPE 2 DIABETES
QUAN Hui-biao,GAO Yong-yi,CHEN Dao-xiong,et al.. CLINICAL COMPARISON OF GLARGINE COMBINED WITH ACARBOSE AND INSULIN ASPART 30 IN TREATMENT OF THE NEWLY DIAGNOSED ELDER TYPE 2 DIABETES[J]. Modern Preventive Medicine, 2011, 38(18): 3816-3817
Authors:QUAN Hui-biao  GAO Yong-yi  CHEN Dao-xiong  et al.
Affiliation:QUAN Hui-biao,GAO Yong-yi,CHEN Dao-xiong,et al.(Department of Endocrinology,Hainan Province People's Hospital,Haikou 570311,China)
Abstract:[Objective]To compare the safety and efficacy of glargine combined with acarbose and insulin aspart 30 in treatment of the newly diagnosed elder type 2 diabetes.[Methods]72 cases newly diagnosed elder type 2 diabetes were randomized divided into two groups.Glargine plus acarbose were used in group A,group B used aspart 30 twice a day.To analysis the time to achieve the target,the dose of insulin and frequency of hypoglycemia between group A and group B.[Results]There was no significant difference between tw...
Keywords:Type 2 diabetes  Elder  Glargine  Acarbose  Insulin aspart 30  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号